Literature DB >> 15331756

Ribavirin therapy for Nipah virus infection.

N J C Snell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15331756      PMCID： PMC515007          DOI： 10.1128/JVI.78.18.10211.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  3 in total

Review 1.  Ribavirin--current status of a broad spectrum antiviral agent.

Authors:  N J Snell
Journal:  Expert Opin Pharmacother       Date:  2001-08       Impact factor: 3.889

2.  Treatment of acute Nipah encephalitis with ribavirin.

Authors:  H T Chong; A Kamarulzaman; C T Tan; K J Goh; T Thayaparan; S R Kunjapan; N K Chew; K B Chua; S K Lam
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

3.  Nipah virus: vaccination and passive protection studies in a hamster model.

Authors:  V Guillaume; H Contamin; P Loth; M-C Georges-Courbot; A Lefeuvre; P Marianneau; K B Chua; S K Lam; R Buckland; V Deubel; T F Wild
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103
  3 in total
  4 in total

Review 1.  Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.

Authors:  Kai Xu; Christopher C Broder; Dimitar B Nikolov
Journal:  Semin Cell Dev Biol       Date:  2011-12-30       Impact factor: 7.727

2.  Computational Identification of Potential Multitarget Inhibitors of Nipah Virus by Molecular Docking and Molecular Dynamics.

Authors:  Vinay Randhawa; Shivalika Pathania; Manoj Kumar
Journal:  Microorganisms       Date:  2022-06-09

3.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28

Review 4.  Molecular strategies to inhibit the replication of RNA viruses.

Authors:  Pieter Leyssen; Erik De Clercq; Johan Neyts
Journal:  Antiviral Res       Date:  2008-02-04       Impact factor: 5.970
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.